Christopherd T. Guiffre

Insider Reports History

Entity
Individual
Location
65 Hayden Ave, Lexington, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopherd T. Guiffre:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. CFO, COO, Treas., & Asst. Sec. Restricted Stock Units 2.29M Feb 15, 2023 Direct
Pear Therapeutics, Inc. CFO, COO, Treas., & Asst. Sec. Stock Option (Right to Buy) 118K Feb 16, 2022 Direct
Pear Therapeutics, Inc. CFO, COO, Treas., & Asst. Sec. Common Stock 49.5K Jan 14, 2023 Direct
Pear Therapeutics, Inc. CFO, COO, Treas., & Asst. Sec. Class A Common Stock 30K Jan 20, 2023 Direct

Insider Reports Filed by Christopherd T. Guiffre

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEARQ Pear Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 CFO, COO, Treas., & Asst. Sec.
PEARQ Pear Therapeutics, Inc. Jan 20, 2023 1 -$22.1K 4 Jan 24, 2023 CFO, COO, Treas., & Asst. Sec.
PEARQ Pear Therapeutics, Inc. Jan 14, 2023 2 $0 4 Jan 18, 2023 CFO, COO, Treas., & Asst. Sec.
PEARQ Pear Therapeutics, Inc. Feb 16, 2022 2 $0 4 Feb 18, 2022 CFO, COO, Treas., & Asst. Sec.
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 5 $0 4 Dec 7, 2021 CFO, COO, Treas., & Asst. Sec.
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 CFO, COO, Treas., & Asst. Sec.